The ROE as of September 2024 (TTM) for BioCardia, Inc. (BCDA) is 526.79%

According to BioCardia, Inc.’s latest financial reports and current stock price. The company's current ROE is 526.79%. This represents a change of 199.80% compared to the average of 175.71% of the last 4 quarters.

BioCardia, Inc. (BCDA) Historical ROE (quarterly & annually)

How has BCDA ROE performed in the past?

The mean historical ROE of BioCardia, Inc. over the last ten years is -86.94%. The current 526.79% ROE has changed -705.95% with respect to the historical average. Over the past ten years (40 quarters), BCDA's ROE was at its highest in in the September 2023 quarter at 390.00%. The ROE was at its lowest in in the March 2019 quarter at -448.04%.

BioCardia, Inc. (BCDA) ROE by Quarter and Year

Discovering the peaks and valleys of BioCardia, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioCardia, Inc. (BCDA) Average ROE

How has BCDA ROE performed in the past?

The current ROE of BioCardia, Inc. (BCDA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BioCardia, Inc. (BCDA) ROE vs. Peers

How is BCDA’s ROE compared to its peers?

BioCardia, Inc.’s ROE is greater than Aerovate Therapeutics, Inc. (-83.65%), greater than Adagene Inc. (-63.48%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.31%), greater than Rezolute, Inc. (-60.90%), greater than AN2 Therapeutics, Inc. (-54.72%), less than ZIVO Bioscience, Inc. (673.84%), greater than Theseus Pharmaceuticals, Inc. (-24.51%), greater than Erasca, Inc. (-131.94%), greater than Forte Biosciences, Inc. (-117.85%), greater than Applied Molecular Transport Inc. (-218.56%), greater than ABVC BioPharma, Inc. (-132.83%), greater than Indaptus Therapeutics, Inc. (-146.70%), greater than Pasithea Therapeutics Corp. (-74.63%), less than Better Therapeutics, Inc. (223.92%), greater than Anebulo Pharmaceuticals, Inc. (-122.97%), greater than Mineralys Therapeutics, Inc. (-42.61%), greater than NervGen Pharma Corp. (-267.77%), greater than Protagenic Therapeutics, Inc. (-238.37%), greater than Miromatrix Medical Inc. (-119.21%),

Build a custom stock screener for BioCardia, Inc. (BCDA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioCardia, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioCardia, Inc. (BCDA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioCardia, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.